1. AB0736 Secukinumab Significantly Improves Physical Function, Quality of Life, and Work Productivity Through 52 Weeks in Subjects with Active Ankylosing Spondylitis in the Phase 3 Measure 2 Study. (9th June 2015) Authors: Deodhar, A.; Sieper, J.; Emery, P.; Porter, B.; Andersson, M.; Richards, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0742 Intravenous Loading and Subcutaneous Maintenance with Secukinumab Provides Sustained Improvement in Multiple Measures of Disease Activity in Subjects with Active Ankylosing Spondylitis: 52-Week Data From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Measure 1 Study. (9th June 2015) Authors: Wei, J. C.-C.; Baeten, D.L.; Geusens, P.; Porter, B.; Martin, R.; Richards, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0743 Secukinumab Improves Multiple Parameters of Disease Activity in Subjects with Active Ankylosing Spondylitis Through 52 Weeks of Subcutaneous Therapy: Data From the Phase 3 Measure 2 Study. (9th June 2015) Authors: Braun, J.; Sieper, J.; Aelion, J.; Emery, P.; Deodhar, A.; Porter, B.; Andersson, M.; Richards, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Additive nanomanufacturing – A review. Issue 17 (4th August 2014) Authors: Engstrom, D.S.; Porter, B.; Pacios, M.; Bhaskaran, H. Journal: Journal of materials research Issue: Volume 29:Issue 17(2014) Page Start: 1792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Human genome meeting 2016. Issue 1 (June 2016) Authors: Srivastava, A.; Wang, Y.; Huang, R.; Skinner, C.; Thompson, T.; Pollard, L.; Wood, T.; Luo, F.; Stevenson, R.; Polimanti, R.; Gelernter, J.; Lin, X.; Lim, I.; Wu, Y.; Teh, A.; Chen, L.; Aris, I.; Soh, S.; Tint, M.; MacIsaac, J. Journal: Human genomics Issue: Volume 10:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Maternal plasma soluble neuropilin‐1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study. (1st November 2021) Authors: Porter, B.; Maulik, D.; Babbar, S.; Schrufer‐Poland, T.; Allsworth, J.; Ye, S. Q.; Heruth, D. P.; Lei, T. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 58:Number 5(2021) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (22nd December 2017) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0060 MACHINE LEARNING BASED BERLIN SCORING OF MAGNETIC RESONANCE IMAGES OF THE SPINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS FROM THE MEASURE 1 STUDY. (2nd June 2020) Authors: Jamaludin, A.; Windsor, R.; Ather, S.; Kadir, T.; Zisserman, A.; Braun, J.; Gensler, L. S.; Machado, P.; Ǿstergaard, M.; Poddubnyy, D.; Coroller, T.; Porter, B.; Mpofu, S.; Readie, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0106 SECUKINUMAB 150 MG SIGNIFICANTLY IMPROVED SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM THE PHASE III PREVENT STUDY. (2nd June 2020) Authors: Braun, J.; Blanco, R.; Dokoupilova, E.; Gensler, L. S.; Kivitz, A.; Hall, S.; Kameda, H.; Poddubnyy, D.; Van de Sande, M.; Van der Heijde, D.; Wiksten, A.; Porter, B.; Richards, H.; Haemmerle, S.; Deodhar, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗